Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Weight loss during telaprevir-based triple therapy due to telaprevir-induced appetite loss.

Internal medicine (Tokyo, Japan) - 1 Jan 2014

Nomura Hideyuki, Miyagi Yuugou, Tanimoto Hironori, Kawano Akira, Yamashita Nobuyuki

Abstract excerpt

OBJECTIVE: The sustained virological response (SVR) rate has improved to >70% for patients with hepatitis C virus genotype 1 treated with the triple therapy of telaprevir (TVR), pegylated interferon (PEG-IFN)-α, and ribavirin (RBV). However, this therapy has various adverse effects, although there have been no reports of it decreasing body weight. METHODS: A total of 175 patients with chronic hepatitis C received...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Appetite
Share to Depression
Share to Ghrelin

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Share to Interferon-beta

Share to Oligopeptides

Share to Polyethylene Glycols

Share to Ribavirin

Share to Weight Loss

Source

Identifiers

PMID: 25400176
DOI: 10.2169/internalmedicine.53.2366

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 7 Sept 2026. Manifest publication-graph-cohort-2026-09-07.1.

Source receipt: pubmed, retrieved 7 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 8 closest

Weight loss during telaprevir-based triple therapy due to telaprevir-induced appetite loss.PMID 25400176Read ↗

Possible Alterations in Appetite-related Molecules After the Elimination of Hepatitis C Virus.Semantic proximity Read ↗

Telaprevir is effective given every 12 h at 750 mg with pegylated interferon-α2b and ribavirin to Japanese patients with HCV-1b IL28B rs8099917 TT.Semantic proximity Read ↗

Glucagon/GLP-1 receptor co-agonist NNC9204-1177 reduced body weight in adults with overweight or obesity but was associated with safety issuesSemantic proximity Read ↗

Telaprevir.Semantic proximity Read ↗

A Growth Differentiation Factor 15 Receptor Agonist in Randomized Placebo-Controlled Trials in Healthy or Obese PersonsSemantic proximity Read ↗

Excess Weight Gain With Integrase Inhibitors and Tenofovir Alafenamide: What Is the Mechanism and Does It Matter?Semantic proximity Read ↗

Rebound weight gain as associated with high plasma norepinephrine levels that are mediated through polymorphisms in the beta2-adrenoceptor.Semantic proximity Read ↗

A placebo-controlled double blind trial of etanercept for the cancer anorexia/weight loss syndrome: results from N00C1 from the North Central Cancer Treatment Group.Semantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.